|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 5/14/20 Mentor Capital, Inc. 10-Q 3/31/20 115:4M Action Edgar Fil… Svc/FA |
Document/Exhibit Description Pages Size
1: 10-Q Form 10-Q Quarterly Report HTML 499K
2: EX-31.1 Exhibit 31.1 Section 302 Certification HTML 41K
3: EX-31.2 Exhibit 31.2 Section 302 Certification HTML 41K
4: EX-32.1 Exhibit 32.1 Section 906 Certification HTML 36K
5: EX-32.2 Exhibit 32.1 Section 906 Certification HTML 36K
42: R1 Document and Entity Information HTML 87K
102: R2 Condensed Consolidated Balance Sheets, (Unaudited) HTML 200K
66: R3 Condensed Consolidated Balance Sheets, (Unaudited) HTML 56K
- Parenthetical
24: R4 Condensed Consolidated Income Statements HTML 126K
(Unaudited)
43: R5 Consolidated Statements of Shareholders' HTML 56K
Equity/Deficit (Unaudited)
103: R6 Condensed Consolidated Statements of Cash Flows HTML 153K
(Unaudited)
67: R7 Note 1 - Nature Of Operations HTML 62K
28: R8 Note 2 - Summary of significant accounting HTML 85K
policies
41: R9 Note 3- Prepaid expenses and other assets HTML 40K
26: R10 Note 4 - Investment in account receivable HTML 44K
39: R11 Note 5 - Property and Equipment HTML 45K
104: R12 Note 6 - Lessee Leases HTML 57K
64: R13 Note 7 - Convertible notes receivable HTML 47K
27: R14 Note 8 - Note purchase agreement and consulting HTML 51K
agreement with G FarmaLabs Limited
40: R15 Note 9 - Finance leases receivable HTML 59K
105: R16 Note 10 - Contractual interest in legal recoveries HTML 47K
65: R17 Note 11 - Concentration of credit risk HTML 42K
25: R18 Note 12 - Investments and Fair Value HTML 79K
44: R19 Note 13 - Common stock warrants HTML 54K
99: R20 Note 14 - Warrant redemption liability HTML 42K
88: R21 Note 15 - Stockholders' Equity HTML 46K
20: R22 Note 16 - Lease Commitments HTML 45K
61: R23 Note 17 - Long Term Debt HTML 42K
100: R24 Note 18 - Accrued salary, accrued retirement and HTML 42K
incentive fee - related party
89: R25 Note 19 - Related Party Transactions HTML 37K
21: R26 Note 20 - Commitments and Contingencies HTML 42K
62: R27 Note 21 - Segment Information HTML 59K
101: R28 Note 22 - Subsequent events HTML 41K
87: R29 Note 2 - Summary of significant accounting HTML 39K
policies: Condensed consolidated financial
statements (Policies)
69: R30 Note 2 - Summary of significant accounting HTML 38K
policies: Basis of presentation (Policies)
108: R31 Note 2 - Summary of significant accounting HTML 40K
policies: Segment reporting (Policies)
38: R32 Note 2 - Summary of significant accounting HTML 41K
policies: Use of Estimates (Policies)
23: R33 Note 2 - Summary of significant accounting HTML 38K
policies: Recent Accounting Standards (Policies)
68: R34 Note 2 - Summary of significant accounting HTML 39K
policies: Newly Issued Not Yet Effective
Accounting Standards (Policies)
107: R35 Note 2 - Summary of significant accounting HTML 38K
policies: Concentrations of cash (Policies)
37: R36 Note 2 - Summary of significant accounting HTML 39K
policies: Cash and Cash Equivalents (Policies)
22: R37 Note 2 - Summary of significant accounting HTML 40K
policies: Accounts Receivable (Policies)
70: R38 Note 2 - Summary of significant accounting HTML 38K
policies: Investments in securities, at fair value
(Policies)
106: R39 Note 2 - Summary of significant accounting HTML 39K
policies: Investment in account receivable, net of
discount (Policies)
80: R40 Note 2 - Summary of significant accounting HTML 41K
policies: Finance leases receivable (Policies)
94: R41 Note 2 - Summary of significant accounting HTML 42K
policies: Credit quality of notes receivable and
finance leases receivable and credit loss reserve
(Policies)
60: R42 Note 2 - Summary of significant accounting HTML 40K
policies: Property and equipment (Policies)
19: R43 Note 2 - Summary of significant accounting HTML 40K
policies: Lessee Leases (Policies)
79: R44 Note 2 - Summary of significant accounting HTML 40K
policies: Long-lived assets impairment assessment
(Policies)
93: R45 Note 2 - Summary of significant accounting HTML 40K
policies: Goodwill (Policies)
59: R46 Note 2 - Summary of significant accounting HTML 39K
policies: Revenue Recognition (Policies)
18: R47 Note 2 - Summary of significant accounting HTML 41K
policies: Basic and diluted income (Loss) Per
Common Share (Policies)
82: R48 Note 2 - Summary of significant accounting HTML 44K
policies: Income Taxes (Policies)
92: R49 Note 2 - Summary of significant accounting HTML 38K
policies: Advertising and Promotion (Policies)
109: R50 Note 2 - Summary of significant accounting HTML 40K
policies: Fair Value Measurements (Policies)
73: R51 Note 3- Prepaid expenses and other assets: HTML 39K
Schedule of Prepaid expenses and other assets
(Tables)
35: R52 Note 4 - Investment in account receivable: HTML 44K
Schedule of Receivables with Imputed Interest
(Tables)
51: R53 Note 5 - Property and Equipment: Property, Plant HTML 44K
and Equipment (Tables)
110: R54 Note 6 - Lessee Leases: Schedule of Lease costs HTML 44K
recognized in Consolidated Statements of
Operations (Tables)
74: R55 Note 6 - Lessee Leases: Schedule of other HTML 40K
information about lease amounts recognized in
Condensed Consolidated Financial Statements
(Tables)
36: R56 Note 6 - Lessee Leases: Schedule of Lease HTML 41K
Liabilities (Tables)
52: R57 Note 7 - Convertible notes receivable: Schedule of HTML 45K
Convertible Notes Receivable (Tables)
111: R58 Note 8 - Note purchase agreement and consulting HTML 42K
agreement with G FarmaLabs Limited: Schedule of
Notes receivable from G Farma (Tables)
72: R59 Note 9 - Finance leases receivable: Schedule of HTML 42K
Net finance leases receivable, non-performing
(Tables)
14: R60 Note 9 - Finance leases receivable: Schedule of HTML 42K
Performing net finance leases receivable (Tables)
53: R61 Note 9 - Finance leases receivable: Schedule of HTML 40K
minimum future payments receivable for performing
finance leases receivable (Tables)
95: R62 Note 12 - Investments and Fair Value: Schedule of HTML 72K
hierarchy of Level 1, Level 2 and Level 3 Assets
(Tables)
83: R63 Note 12 - Investments and Fair Value: Schedule of HTML 39K
amortized costs, gross unrealized holding gains
and losses, and fair values of Available-for-sale
Securities (Tables)
17: R64 Note 12 - Investments and Fair Value: Schedule of HTML 41K
unrealized gains and losses on Available-for-sale
Securities held at the reporting date (Tables)
56: R65 Note 13 - Common stock warrants: Schedule of HTML 43K
Series B and Series D common stock warrants
(Tables)
98: R66 Note 13 - Common stock warrants: Schedule of HTML 40K
Series E, F, G and H warrants (Tables)
86: R67 Note 16 - Lease Commitments: Schedule of Lease HTML 42K
Commitments (Tables)
12: R68 Note 17 - Long Term Debt: Schedule of Long term HTML 43K
debt and revolving line of credit (Tables)
57: R69 Note 18 - Accrued salary, accrued retirement and HTML 40K
incentive fee - related party: Schedule of
Outstanding Liability (Tables)
50: R70 Note 21 - Segment Information: Schedule of Segment HTML 50K
Information (Tables)
32: R71 Note 21 - Segment Information: Reconciliation of HTML 43K
Revenue from Segments to Consolidated (Tables)
78: R72 Note 1 - Nature Of Operations (Details) HTML 38K
115: R73 Note 2 - Summary of significant accounting HTML 37K
policies: Goodwill (Details)
47: R74 Note 2 - Summary of significant accounting HTML 37K
policies: Advertising and Promotion (Details)
29: R75 Note 3- Prepaid expenses and other assets: HTML 44K
Schedule of Prepaid expenses and other assets
(Details)
75: R76 Note 4 - Investment in account receivable: HTML 44K
Schedule of Receivables with Imputed Interest
(Details)
112: R77 Note 4 - Investment in account receivable HTML 37K
(Details)
46: R78 Note 5 - Property and Equipment: Property, Plant HTML 52K
and Equipment (Details)
34: R79 Note 5 - Property and Equipment (Details) HTML 38K
49: R80 Note 6 - Lessee Leases: Schedule of Lease costs HTML 50K
recognized in Consolidated Statements of
Operations (Details)
31: R81 Note 6 - Lessee Leases (Details) HTML 46K
77: R82 Note 6 - Lessee Leases: Schedule of other HTML 43K
information about lease amounts recognized in
Condensed Consolidated Financial Statements
(Details)
114: R83 Note 6 - Lessee Leases: Schedule of Lease HTML 44K
Liabilities (Details)
48: R84 Note 7 - Convertible notes receivable: Schedule of HTML 46K
Convertible Notes Receivable (Details)
30: R85 Note 8 - Note purchase agreement and consulting HTML 44K
agreement with G FarmaLabs Limited: Schedule of
Notes receivable from G Farma (Details)
76: R86 Note 9 - Finance leases receivable: Schedule of HTML 48K
Net finance leases receivable, non-performing
(Details)
113: R87 Note 9 - Finance leases receivable: Schedule of HTML 46K
Performing net finance leases receivable (Details)
45: R88 Note 9 - Finance leases receivable: Schedule of HTML 49K
minimum future payments receivable for performing
finance leases receivable (Details)
33: R89 Note 12 - Investments and Fair Value: Schedule of HTML 59K
hierarchy of Level 1, Level 2 and Level 3 Assets
(Details)
15: R90 Note 12 - Investments and Fair Value: Schedule of HTML 44K
amortized costs, gross unrealized holding gains
and losses, and fair values of Available-for-sale
Securities (Details)
54: R91 Note 12 - Investments and Fair Value: Schedule of HTML 41K
unrealized gains and losses on Available-for-sale
Securities held at the reporting date (Details)
96: R92 Note 13 - Common stock warrants (Details) HTML 45K
84: R93 Note 13 - Common stock warrants: Schedule of HTML 46K
Series B and Series D common stock warrants
(Details)
16: R94 Note 13 - Common stock warrants: Schedule of HTML 40K
Series E, F, G and H warrants (Details)
55: R95 Note 15 - Stockholders' Equity (Details) HTML 45K
97: R96 Note 16 - Lease Commitments: Schedule of Lease HTML 60K
Commitments (Details)
85: R97 Note 17 - Long Term Debt: Schedule of Long term HTML 42K
debt and revolving line of credit (Details)
13: R98 Note 18 - Accrued salary, accrued retirement and HTML 42K
incentive fee - related party: Schedule of
Outstanding Liability (Details)
58: R99 Note 21 - Segment Information: Schedule of Segment HTML 63K
Information (Details)
91: R100 Note 21 - Segment Information: Reconciliation of HTML 46K
Revenue from Segments to Consolidated (Details)
81: R101 Note 22 - Subsequent events (Details) HTML 64K
71: XML IDEA XML File -- Filing Summary XML 233K
63: EXCEL IDEA Workbook of Financial Reports XLSX 108K
8: EX-101.INS XBRL Instance -- mntr-20200331 XML 956K
6: EX-101.CAL XBRL Calculations -- mntr-20200331_cal XML 200K
7: EX-101.DEF XBRL Definitions -- mntr-20200331_def XML 236K
9: EX-101.LAB XBRL Labels -- mntr-20200331_lab XML 812K
10: EX-101.PRE XBRL Presentations -- mntr-20200331_pre XML 647K
11: EX-101.SCH XBRL Schema -- mntr-20200331 XSD 257K
90: ZIP XBRL Zipped Folder -- 0001078782-20-000323-xbrl Zip 118K
| Exhibit 31.1 Section 302 Certification |
Quarter ended March 31, 2020
CERTIFICATION OF PERIODIC REPORT UNDER SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002
I, Chet Billingsley, certify that:
1.I have reviewed this quarterly report on Form 10-Q of Mentor Capital, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15€ and 15d-15€) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
Date: | |
|
|
| /s/ CHET BILLINGSLEY |
| |
| Chairman of the Board of Directors and Chief Executive Officer |
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 5/14/20 | None on these Dates | ||
| 5/13/20 | ||||
| For Period end: | 3/31/20 | |||
| List all Filings | ||||